Zürcher Kantonal Bank

Annaida Technologies SA, founded in 2019 and based in Lausanne, Switzerland, specializes in the development of innovative healthcare devices. The company has created EmbryoSpin, a device that performs microscopic Nuclear Magnetic Resonance (µNMR) with a sensitivity that surpasses existing technologies by tenfold. This groundbreaking device is designed to operate at the scale of a single human embryo, providing a robust and user-friendly solution for researchers. EmbryoSpin facilitates non-invasive embryo viability screening for in-vitro fertilization and enhances biochemical research by allowing detailed chemical analysis of microscopic samples. Annaida Technologies' advancements aim to improve outcomes in reproductive health and deepen understanding in various areas of biochemical research.

DePoly is a chemical recycling company focused on addressing the global plastic waste issue through its innovative recycling technology. The company specializes in converting post-consumer PET plastic and polyester textiles into their original raw materials at room temperature, eliminating the need for pre-washing, pre-sorting, or separating other plastics. This efficient process ensures that the quality of the recycled materials is maintained, regardless of their source or condition. By supplying these high-quality raw materials back to the industry, DePoly contributes to the creation of a circular plastic economy, enabling the production of new plastic items in a sustainable and environmentally friendly manner.

AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.

Dphi Space is a pioneering company focused on facilitating affordable access to space for small satellites. They specialize in aggregating multiple satellite payloads onto shared launches, coordinating with launch providers, and managing the entire deployment process. This approach enables researchers to deploy their satellites more quickly and cost-effectively, reducing dependence on dedicated launches and optimizing capacity utilization.

Eleven Dynamics is a software technology developer focused on automating quality control processes across various industries. Their innovative software enables businesses to design and simulate customized quality processes efficiently. It automates the programming of measurement paths, allowing for optimal process timing without requiring expertise in robotics. Additionally, Eleven Dynamics' technology facilitates real-time connections between hardware components and oversees the execution of measurement processes, offering clients tailored robotic solutions to enhance their operational efficiency.

Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.

embotech AG, founded in 2013 and based in Zurich, Switzerland, specializes in developing software solutions for autonomous systems that focus on numerical optimization. Their flagship product, FORCES Pro, allows for the effective design of complex control systems by solving intricate optimization problems rapidly. The software has diverse applications, including the control of wind turbines, collision-free motion planning for autonomous drones, the enhancement of advanced driver assistance systems, and enabling precise landings for spacecraft on other planets, as well as the retrieval of reusable rockets. Embotech caters to various sectors, including automotive, energy, and robotics, positioning itself as a leader in creating advanced decision-making technologies essential for future autonomous systems.

RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.

Somagenetix is a biotechnology company specializing in gene therapy aimed at treating phagocyte-related illnesses. The firm focuses on developing innovative treatments for conditions such as immunodeficiency, neurodegeneration, and cancer with brain metastases. By utilizing genetically modified phagocytes, Somagenetix seeks to improve patient outcomes through targeted therapies. Additionally, the company is engaged in the discovery and development of stem cells derived from bone marrow and therapeutic genes from lentiviral vectors. This approach enables the correction of underlying genetic defects and the transplantation of gene-corrected cells back into patients, with the goal of curing various monogenetic diseases. Through its pioneering efforts, Somagenetix aspires to be a leader in the gene therapy sector.

Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.

AskEarth is a Swiss-based startup founded by researchers from the University of Zurich (UZH), ETH Zurich, and EPFL. It operates a geospatial intelligence platform that processes real-time satellite imagery to provide accurate, up-to-date information about Earth's surface changes. The company specializes in monitoring deforestation, coastline progressions, glacier melting, and transportation infrastructure, with a focus on supporting the European Union's Deforestation Regulation (EUDR). AskEarth offers an easy-to-use tool for clients to access unique earth observation data, enabling them to validate news articles and gain insights into planetary changes with just one click.

Isochronic is a manufacturer of advanced industrial robotic products designed for pick-and-place applications. The company focuses on developing next-generation robots that can transport multiple parts simultaneously, thus enhancing efficiency in high-volume production lines. By enabling industries to automate their operations, Isochronic significantly increases the number of products processed at any given time while optimizing the use of factory floor space. Its innovative approach aims to revolutionize the traditional pick-and-place methods, providing businesses with the tools necessary for streamlined operations and enhanced productivity.

Calingo is a digital insurance platform that specializes in providing personalized and optimized risk protection directly at the point of sale. The company focuses on offering customized insurance products designed to meet individual customer needs, ensuring transparency and fairness in pricing. By leveraging technology, Calingo aims to deliver tailored insurance solutions that are both suitable and transparent for customers.

Complementa, established in 1984 and based in Saint Gallen, Switzerland, offers a range of services to support investors. These include consolidated performance reporting, accounting, investment consulting, and investment control. The company assists clients in planning, designing, and monitoring their investment and financing processes.

Drone Harmony, established in 2016, specializes in developing innovative software solutions to enhance the deployment of drone technology across various industries. The company's flagship product is a sophisticated 3D flight planning software that transforms commercial drone operations by enabling automated and scalable inspection tasks. By leveraging advanced algorithms, Drone Harmony simplifies complex industrial inspections, making it accessible for anyone with a drone to become an inspection professional. Their platform supports data-driven mission planning and 4D asset modeling, facilitating the scaling of drone-based data capture workflows from small projects to large enterprise-wide operations. This focus on automation and process efficiency is crucial for the broader adoption of drones in industries where traditional technologies fall short.

Synthara AG is a Swiss semiconductor startup specializing in the development of smart sensors for industrial Internet of Things (IoT) and energy-efficient applications. Founded in 2019 and headquartered in Zurich, the company focuses on creating advanced computational AI chips that enhance the performance of embedded systems. Its flagship product, ComputeRAM, functions as a drop-in replacement for traditional SRAM, enabling complex calculations directly in memory. This innovation significantly reduces CPU workload and enhances system efficiency, particularly for AI-driven applications. Synthara's technology is processor-type agnostic, compatible with various architectures including RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By offering solutions that lower costs and accelerate time to market, Synthara aims to empower chipmakers and device manufacturers to explore new opportunities in sectors such as wearables, biomedical monitoring, and autonomous navigation.

Microcaps AG is a company based in Zurich, Switzerland, founded in 2018, specializing in the development of advanced microencapsulation technology. The firm focuses on creating devices that facilitate the precise production of monodisperse microcapsules and microparticles through innovative microfluidics. Microcaps' solutions are designed to enhance drug delivery systems and probiotic encapsulation, while also providing tailored offerings for various applications, including pharmaceuticals and cosmetics. Their cutting-edge technology enables scalable, fully-automated production that allows for size control, precise dosing, and improved stability of the encapsulated materials. By utilizing a step emulsification device, Microcaps enhances production capacity and throughput rates without compromising quality, making it a pivotal player in the field of microencapsulation.

DataHow AG is a spin-off from ETH Zurich that specializes in data analytics and process modeling for the biopharmaceutical and chemical industries. The company offers digital solutions and consulting services aimed at optimizing process monitoring and scale-up. By focusing on reducing effort, risks, and costs associated with process development, DataHow enhances clients' understanding of complex manufacturing processes. Their services include process screening, monitoring, optimization, and control, providing technological support that enables businesses in these sectors to improve efficiencies in manufacturing and development.

RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.

Testmate Health is a medtech startup and an award-winning spin-off from the University of Geneva, Switzerland. The company has developed a smartphone-compatible platform that offers a test kit capable of diagnosing diseases with identifiable DNA or RNA sequences without laboratory involvement, providing rapid results at home in minutes. Their initial product is a user-friendly, all-in-one kit that serves as the first rapid urine self-test for the four most common sexually transmitted diseases (STDs). Given that one million new STDs are diagnosed daily, Testmate Health addresses a critical gap in the market, as traditional testing often requires lab processing and can take up to a week for results. The kit not only delivers immediate results but also allows users to scan their results with a smartphone, facilitating quick access to treatment if necessary. Additionally, Testmate Health has plans to expand its offerings with test kits for other diseases, empowering individuals to manage their health conveniently from home.

Bcomp Ltd. is a Fribourg-based manufacturer specializing in natural fiber composites, founded in 2003. The company produces a range of innovative products, including ampliTex, which utilizes natural flax fibers, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies are designed to replace traditional materials such as aluminum, carbon, or glass fiber composites, providing solutions that enhance weight efficiency, rigidity, shock absorption, and damping. The company serves various industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure. Bcomp has developed a robust portfolio of intellectual property, including patents and specific processing technologies derived from aerospace and marine applications. The company prioritizes collaboration with customers and academic partners to tailor its products to meet specific industry needs while advancing its research and development efforts.

Autonomous Testing with Zero Flakiness. The TrueTest Technology and our AI-based virtual user makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. We simplified automated testing massively and reduced time radically. With it, the automation and maintenance effort is reduced to a minimum: zero flakiness and the enlightening feeling of being in control of your automation and test scenarios. It's not about buzzwords and being one of the cool kids. Our mission was to solve the daily problems of test automation. And that's what we did. OUR TECHNOLOGY Stop losing your time on tasks automation should have eliminated The power of TestResults.io lies in its core, the TrueTest technology. It includes Visual Matching, Visual Sense, and Codified Expertise. Visual Matching Identifies elements in a technology-agnostic way through image convolution, text detection, and our unique ReverseOCR Visual Sense Identifies interaction position without hints to solve flakiness with spatial algorithms and automatic candidate selection. It doesn’t matter if the label is outside or inside, above, left from the field or anywhere else. It doesn’t matter if the position changes in a responsive layout. Visual Sense, always knows what label is related to which field. Codified Expertise Knows how to interact with elements through autonomous interactions and automatic verification.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Cultivated Biosciences is a food production company focused on developing specialized fat ingredients derived from oleaginous yeast to enhance plant-based dairy products. The company aims to improve the mouthfeel and creaminess of animal-free cheese and yogurt, providing healthier alternatives to traditional dairy. Its yeast-based ingredients maintain a clean label and support sustainable production processes while mirroring the texture and color of conventional dairy. Additionally, these ingredients feature low lipid oxidation and natural emulsification properties, contributing to a superior sensory experience for consumers seeking plant-based options.

Food Brewer AG is a Switzerland-based company specializing in the development and marketing of innovative food and food ingredients through the use of plant cell cultures. By employing technologies similar to beer brewing for large-scale cultivation in fermenters, Food Brewer provides sustainable alternatives to traditional agriculture. The company focuses on securing essential resources for the food industry while addressing geographic, climatic, and ethical uncertainties associated with conventional farming practices. Its product offerings include alternatives to cocoa, coffee, nuts, and grains, catering to the evolving needs of clients seeking sustainable food solutions.

Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

Qumea is a medical technology company that specializes in discreet patient monitoring, focusing on fall prevention and mobility tracking within hospitals and care institutions. By integrating artificial intelligence with advanced 3D radar technology, Qumea offers an innovative solution that enhances patient safety while alleviating the burden on caregivers. Their system utilizes a three-dimensional radar sensor combined with cloud-based applications to create a seamless early-warning mechanism. This technology not only supports caregivers in effectively preventing falls but also contributes to significant cost savings for healthcare facilities.

BTRY, spun off from EMPA and ETH, specializes in developing the first energy-dense solid-state battery, leveraging advanced semiconductor manufacturing techniques. The company aims to provide a sustainable energy storage solution, offering customizable battery properties to meet diverse customer needs, thereby reducing energy consumption and waste from solvent evaporation and recycling.

Scientific Instrumentation and Services

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

Aesyra SA is a Swiss company founded in 2017 and headquartered in Lausanne. It specializes in the design and manufacture of medical devices, particularly the AesyBite, an intra-oral sensor that monitors and alleviates sleep bruxism. Aesyra's technology is aimed at assisting dental professionals by reducing damage to dental prostheses caused by occlusal issues. The company focuses on enhancing the care of individuals with sleep disorders by providing tools that perform intraoral measurements during sleep. These measurements help in detecting bruxism, obstructive sleep apnea, and other related conditions. Through its innovative solutions, Aesyra enables healthcare professionals to accurately monitor patient activities and implement biofeedback treatments to improve sleep quality.

Onena Medicines is a biotechnology company focused on developing innovative biological therapies to meet significant clinical needs, particularly in breast cancer and other serious orphan diseases. The company utilizes a proprietary antibody drug discovery platform that leverages advanced artificial intelligence to reprogram cancer cells for the treatment of advanced cancers. This platform enables the design of custom antibodies that exhibit high selectivity and specificity, linked to specialized cellular reprogramming assays. The therapeutic candidates developed by Onena Medicines modulate the activity of a novel class of growth factors known as dual smad inhibiting protein dips, which are implicated in the growth and metastasis of cancer. Through its pioneering approach, Onena Medicines aims to provide physicians with access to groundbreaking drugs in areas where medical needs remain unaddressed.

Helio is a technology company focused on optimizing cloud computing to reduce carbon emissions and improve efficiency. Its platform utilizes an application program interface that matches workloads with available computing resources, leveraging containerized workloads and cloud-native principles. This approach allows Helio to execute applications such as 3D rendering and machine learning in a carbon-aware manner, ensuring minimal environmental impact while maintaining cost-effectiveness and scalability. By providing secure technical layers between users, Helio enables businesses to efficiently manage their large-scale workloads and enhance operational speed, addressing the significant energy consumption and resource waste prevalent in traditional data centers.

Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

Tune Insight is a developer of data security software that facilitates secure collaborations on sensitive data among multiple organizations. The company employs advanced collective analytics, privacy measures, and encryption technologies to enable federated learning. This approach allows participants to derive insights collectively while maintaining full control over their own data. By focusing on secure data sharing, Tune Insight empowers organizations to make informed decisions collaboratively, ensuring both data integrity and privacy throughout the process.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.

Nezasa is a travel technology company that provides a comprehensive booking solution designed to enhance the travel planning experience for brands worldwide. Its platform enables the integration of various travel services into a single, user-friendly interface, allowing for the seamless planning and booking of multi-product or multi-stop itineraries. Nezasa's offerings include TripBuilder, which facilitates real-time planning and hyper-personalized packaging of trips, and TripBooster, which enhances in-destination upselling opportunities. The company’s technology combines the efficiency of online portals with the personalized touch of traditional travel agencies, allowing tour operators and travel retailers to automate and customize their travel offerings. By leveraging standardized and customizable APIs within a secure cloud-based environment, Nezasa supports the immediate booking of tailored trips, making it a valuable partner for travel brands seeking to optimize their customer experience.

DePoly is a chemical recycling company focused on addressing the global plastic waste issue through its innovative recycling technology. The company specializes in converting post-consumer PET plastic and polyester textiles into their original raw materials at room temperature, eliminating the need for pre-washing, pre-sorting, or separating other plastics. This efficient process ensures that the quality of the recycled materials is maintained, regardless of their source or condition. By supplying these high-quality raw materials back to the industry, DePoly contributes to the creation of a circular plastic economy, enabling the production of new plastic items in a sustainable and environmentally friendly manner.

Distran is a technology company that originated as a spin-off from the Autonomous System Lab at ETH Zurich. It specializes in the development of advanced acoustic sensors, specifically phased-array sensors, aimed at enhancing safety for industrial workers and minimizing environmental impact. Distran's innovative ultrasound cameras are designed for various industries, including oil and gas, power generation, chemistry, and composite engineering. These sensors effectively spatially filter sounds, allowing for the precise detection of defects, such as leaks or discharges, from a safe distance. By improving the ability to assess machine conditions, Distran provides solutions that not only protect workers but also contribute to more environmentally sustainable industrial practices.

UniSieve Ltd is a cleantech company based in Zurich, Switzerland, specializing in the development and manufacturing of mechanically flexible molecular sieving membranes. Founded in 2018, UniSieve utilizes a unique platform technology that combines various molecular sieves with polymeric membranes to create reliable separation solutions. These membranes are designed for a diverse array of applications, including chemical feedstock purification, biogas upgrading, gas and liquid separation, sensing, and space-related uses. By providing advanced molecular separation systems, UniSieve aims to enhance energy efficiency, reduce carbon dioxide emissions, and improve recycling rates for its clients, ultimately contributing to operational cost savings.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in marketing analytics. The company offers a platform designed to provide insights into marketing data and actionable recommendations for enhancing marketing performance through artificial intelligence. By aggregating Key Performance Indicators from various tools such as Google Ads and Facebook, Nexoya's platform evaluates the optimal allocation of advertising budgets across different channels. The features of the platform include predictive analytics, cross-channel reporting, anomaly detection, and campaign optimization, all aimed at helping clients maximize their return on advertising spend and achieve better results from their marketing strategies.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.

Correntics is a company focused on enhancing the resilience of global supply chains through a climate risk assessment platform. By employing a data-driven approach, it provides clients with comprehensive insights into their supply chains, covering aspects from raw material availability to final delivery. The platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling businesses to identify and mitigate potential disruptions. Correntics aims to improve operational efficiency and financial stability for its clients while addressing the challenges posed by climate change and emerging risks, ultimately supporting the sustainability of their business activities.

Medyria AG is a Swiss medical technology company focused on developing innovative sensor-based systems for catheter navigation and sensing in cardiovascular procedures. Founded in 2012 and based in Winterthur, Switzerland, Medyria engineers devices that enhance the safety and effectiveness of endovascular surgeries. Its product lineup includes a catheter positioning system that eliminates the need for X-rays and contrast dyes, a blood flow measurement system known as Flowcath, and the Trackcath technology, which processes flow data to facilitate catheter tracking. These technologies aim to streamline minimally invasive procedures, reduce potential complications, and lower overall treatment costs, thereby supporting healthcare professionals in delivering optimal patient care. Medyria operates with a commitment to advancing medical devices that prioritize patient safety and procedural efficiency.

Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of advanced solar panels. The company has achieved record efficiency levels of 29 percent for its solar modules, significantly lowering residential solar electricity costs. Insolight utilizes innovative optical technology that combines high efficiency with the ease of mounting similar to standard flat panels. The company has also demonstrated its capabilities through third-party validations, achieving 36 percent efficiency on lab prototypes and 29 percent on pre-industrial modules. Insolight's business model focuses on developing intellectual property, controlling wholesale distribution, and outsourcing manufacturing. Additionally, the company is engaged in creating photovoltaic systems aimed at reducing solar electricity costs in the agricultural sector, employing integrated tracking methods to optimize energy production based on the sun's position.

TerraRad Tech specializes in the development and marketing of advanced electromagnetic remote sensing devices designed to optimize agricultural efficiency and sustainability. The company offers drone and vehicle-mounted sensors that measure soil moisture and crop water content, providing actionable data that aids in reducing water usage while enhancing agricultural productivity. Its product line, including turfRad, specifically targets golf courses, facilitating significant irrigation water savings through a combination of sensor hardware and a Software as a Service (SaaS) model. By focusing on innovative solutions, TerraRad Tech aims to improve soil moisture measurement systems for both unmanned aerial vehicles and ground-based applications.

Navignostics is a biotechnology company focused on improving cancer treatment through advanced diagnostic techniques. By employing spatial single-cell proteomics, Navignostics characterizes tumors to identify the most effective treatment strategies for individual cancer patients. The company aims to reduce patient suffering by personalizing cancer therapies and ensuring that the right drug is available for each unique case. In addition to enhancing patient outcomes, Navignostics accelerates cancer drug development by offering valuable insights into drug mechanisms and tumor characteristics, which are essential for the creation of companion diagnostics. Their robust technology and data analytics capabilities position the company as a key player in precision cancer diagnostics, providing support to both patients and pharmaceutical partners in the fight against cancer.

Vestr is a technology company that specializes in providing a comprehensive software-as-a-service platform designed for the management of actively managed investment products. The company focuses on digitizing the entire value chain of active management, offering tools that facilitate portfolio management, order execution, and performance reporting. By streamlining these processes, Vestr enables issuers and portfolio managers to concentrate on their core competencies while efficiently managing their portfolios. The platform addresses the complexities of active management, allowing clients to make informed investment decisions and mitigate risk without issuing its own structured products.

Avelo is a manufacturer of breath aerosol diagnostic equipment focused on providing rapid testing solutions for infectious diseases. The company has developed a non-invasive sample-to-answer breath test that reliably detects multiple lower respiratory tract infections within minutes. This process involves three simple steps, allowing healthcare providers to make timely and informed decisions regarding antibiotic or antiviral treatments. Avelo's innovative approach aims to enhance the speed and accuracy of diagnoses in primary care settings, ultimately contributing to improved patient outcomes and the potential to save lives through early intervention.

Skribble is an electronic signature platform founded in 2018 and headquartered in Zurich, Switzerland. It provides a legally compliant solution for signing contracts electronically, ensuring that digital signatures carry the same legal weight as handwritten signatures under Swiss and EU law. The platform facilitates the signing process by allowing users to upload documents and manage signatures between parties, all with just a few clicks. Skribble aims to simplify the contract signing experience while maintaining the necessary legal integrity, making it a valuable tool for individuals and businesses seeking efficient document management.

Piomic Medical is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly leg and foot ulcers. The company has created the COMS® One Therapy System, a portable, hand-held device that utilizes optical and magnetic stimulation technologies to promote wound healing. This device is designed to be user-friendly, featuring a single button operation, and can be utilized in both clinical settings and patients' homes. Clinical studies have demonstrated that the COMS® system is safe and effective, resulting in accelerated wound closure, reduced pain, and improved quality of life for patients. By providing a lightweight and efficient solution, Piomic Medical addresses the significant challenge posed by hard-to-heal wounds, which affect millions of individuals and impose a considerable burden on healthcare systems worldwide.

Pipra is a MedTech startup focused on developing innovative tools aimed at preventing, predicting, and diagnosing delirium, particularly postoperative delirium, which significantly affects older patients and incurs substantial costs for healthcare systems. The company offers an AI-driven clinical decision support software designed to help healthcare professionals identify patients at high risk of developing postoperative delirium prior to surgery. The tool utilizes standard medical data and delivers a risk assessment in under two minutes through a web or app-based platform. This capability allows medical staff to tailor operative plans and implement clinical interventions, ultimately reducing the incidence of postoperative delirium by up to 53%. Currently, Pipra's technology is operational in three hospitals, with plans to expand to 22 additional facilities across Europe. The company's advisory board includes notable experts from prestigious institutions such as Johns Hopkins, Harvard, and Cornell, further underscoring its commitment to addressing this critical healthcare issue.

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

Smeetz SA is a Swiss-based company that operates an online booking platform designed for the leisure and entertainment industry. Established in 2016 and headquartered in Lausanne, Smeetz offers an AI-powered commerce intelligence platform that integrates various tools for ticketing, payment processing, and event management. Its comprehensive solutions include features such as dynamic pricing, data analytics, reservation management, and cross-channel sales, all aimed at enhancing operational efficiency and maximizing revenue for venues. By leveraging insights derived from artificial intelligence, Smeetz empowers event organizers to optimize marketing strategies and improve guest experiences, thereby facilitating the digital transformation of the leisure sector.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Isochronic is a manufacturer of advanced industrial robotic products designed for pick-and-place applications. The company focuses on developing next-generation robots that can transport multiple parts simultaneously, thus enhancing efficiency in high-volume production lines. By enabling industries to automate their operations, Isochronic significantly increases the number of products processed at any given time while optimizing the use of factory floor space. Its innovative approach aims to revolutionize the traditional pick-and-place methods, providing businesses with the tools necessary for streamlined operations and enhanced productivity.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in the manufacture of 3D printers that produce carbon fiber composites. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Its proprietary Additive Fusion Technology enables the creation of lightweight structural parts with precise fiber orientation, allowing for the mass production of carbon composites at reduced costs. The intuitive design software facilitates optimal fiber placement, while automated production equipment enhances efficiency and competitiveness across the manufacturing value chain. 9T Labs’ technology simplifies the production of performance parts, making them more accessible for various applications, including drones and prosthetics.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Drone Harmony, established in 2016, specializes in developing innovative software solutions to enhance the deployment of drone technology across various industries. The company's flagship product is a sophisticated 3D flight planning software that transforms commercial drone operations by enabling automated and scalable inspection tasks. By leveraging advanced algorithms, Drone Harmony simplifies complex industrial inspections, making it accessible for anyone with a drone to become an inspection professional. Their platform supports data-driven mission planning and 4D asset modeling, facilitating the scaling of drone-based data capture workflows from small projects to large enterprise-wide operations. This focus on automation and process efficiency is crucial for the broader adoption of drones in industries where traditional technologies fall short.

Nanoleq AG is a Swiss company founded in 2017 and based in Zurich, specializing in the development and manufacture of electric cables utilizing stretchable electronics. As a spinoff from ETH Zurich, Nanoleq focuses on integrating electronic functionality into textiles, particularly for health monitoring. The company creates soft sensors that can track vital signs such as heart rate, electrocardiograms, and breathing patterns through washable and comfortable garments. Their innovative conductive silicone technology allows for the monitoring of various physiological parameters while maintaining user comfort. Nanoleq aims to establish a standard for health-monitoring textiles, making significant strides in sectors such as healthcare, robotics, aerospace, and general electronics, while also working on further advancements in textile sensor technology.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in the design and manufacture of innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that features a combination of wheels and tracks, which allows users to navigate various terrains and obstacles, including curbs and uneven surfaces. With an active control system that ensures stability and balance, the wheelchair can be operated through a joystick or a shift in body weight, enabling users to maintain independence and enhance their mobility in everyday life.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

RoomPriceGenie AG, founded in 2017 and based in Steinhausen, Switzerland, specializes in designing and developing revenue management software tailored for hotels, apartments, and vacation rentals. The company's platform offers sophisticated yielding, strategy foresight, and automated updates to optimize room pricing based on demand, occupancy, and availability. By leveraging advanced dynamic pricing algorithms and real-time analytics, RoomPriceGenie ensures optimal pricing strategies. It integrates seamlessly with various property management systems and channel managers, providing both automated pricing adjustments and manual control options. This makes it a versatile tool for small to medium-sized hotels aiming to boost their revenue efficiently. The platform is known for its user-friendly interface and excellent customer support.

ELDICO Scientific AG is a Swiss company founded in 2019 and located at the Switzerland Innovation Park Innovaare, which is affiliated with the Paul Scherrer Institute. The company specializes in the development, manufacturing, and sale of electron diffractometers designed for the analysis of solid compounds, particularly targeting nano-crystalline systems in the sub-micrometer range. ELDICO's innovative instruments enable industrial and scientific researchers to characterize materials that were previously challenging to measure, thereby facilitating advancements in fields such as pharmaceuticals, agrochemicals, and advanced materials research. The company achieved proof of concept for its technology in 2018, with recognition from reputable scientific communities, including being named a Top 5 "Breakthrough of the Year" by a leading journal. This groundbreaking work positions ELDICO as a key player in enhancing the speed and cost-effectiveness of structural analysis, ultimately contributing to faster drug discovery and development processes.

Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in marketing analytics. The company offers a platform designed to provide insights into marketing data and actionable recommendations for enhancing marketing performance through artificial intelligence. By aggregating Key Performance Indicators from various tools such as Google Ads and Facebook, Nexoya's platform evaluates the optimal allocation of advertising budgets across different channels. The features of the platform include predictive analytics, cross-channel reporting, anomaly detection, and campaign optimization, all aimed at helping clients maximize their return on advertising spend and achieve better results from their marketing strategies.

Futurae, established in 2016 as a spin-off from ETH Zurich, specializes in enhancing the authentication process for users and businesses. The company provides a comprehensive Authentication Platform that incorporates AI-based solutions and regulatory-compliant products, such as those aligned with PSD2 and Strong Customer Authentication (SCA). By focusing on reducing user friction and improving overall user experience, Futurae aims to streamline the authentication process, which in turn lowers support costs for businesses. The platform supports over 130 clients, including banks, insurance companies, online retailers, and digital wallets, by offering real-time fraud detection and enabling adaptive online security. Through its innovative approach, Futurae is committed to facilitating seamless user journeys while maintaining high security standards.

Apiax AG is a Swiss company founded in 2017, with offices in Zürich, Lisbon, and London, specializing in digital compliance solutions for the financial sector. It enables banks and FinTech companies to convert complex regulatory requirements into straightforward digital compliance rules. By leveraging machine learning and a high-performance architecture, Apiax provides an embedded compliance solution that allows financial institutions to integrate compliance seamlessly into their existing workflows and applications. This innovative approach helps organizations address regulatory challenges, capitalize on business opportunities, and reduce compliance costs, ultimately enhancing their operational efficiency and decision-making processes.

Microcaps AG is a company based in Zurich, Switzerland, founded in 2018, specializing in the development of advanced microencapsulation technology. The firm focuses on creating devices that facilitate the precise production of monodisperse microcapsules and microparticles through innovative microfluidics. Microcaps' solutions are designed to enhance drug delivery systems and probiotic encapsulation, while also providing tailored offerings for various applications, including pharmaceuticals and cosmetics. Their cutting-edge technology enables scalable, fully-automated production that allows for size control, precise dosing, and improved stability of the encapsulated materials. By utilizing a step emulsification device, Microcaps enhances production capacity and throughput rates without compromising quality, making it a pivotal player in the field of microencapsulation.

Synendos Therapeutics AG is a biopharmaceutical company based in Allschwil, Switzerland, founded in 2019. It specializes in developing therapies for neuropsychiatric disorders, particularly focusing on anxiety, mood, and stress-related conditions. The company is pioneering a new class of small molecules that target the endocannabinoid system to restore natural brain function. By modulating cannabinoid activity and inhibiting endocannabinoid transport across cell membranes, Synendos aims to rebalance altered neurotransmission in various areas of the brain. This innovative approach addresses significant unmet medical needs, particularly for conditions such as post-traumatic stress disorder (PTSD), where there is a high demand for effective pharmacological treatments.

Voliro is an innovative company specializing in mobile robotics, particularly focused on contact-based work at heights. Their advanced flying robots are designed for precision and versatility, surpassing traditional drones by enabling direct interaction with the environment. Central to their technology is a proprietary tiltable rotor system, which transforms conventional drones into sophisticated robotic platforms capable of performing complex tasks. Voliro’s unique 360° drone design allows for effective inspection of curved and sloped surfaces, setting them apart in the industry. The company offers a variety of payload options, including Non-Destructive Testing (NDT) sensors and Lightning Protection System (LPS) sensors, enhancing the safety and efficiency of asset inspections. By providing automated nondestructive testing, ultrasonic thickness measurements, and thermal imaging, Voliro delivers faster, more reliable, and cost-effective monitoring services for clients.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of advanced solar panels. The company has achieved record efficiency levels of 29 percent for its solar modules, significantly lowering residential solar electricity costs. Insolight utilizes innovative optical technology that combines high efficiency with the ease of mounting similar to standard flat panels. The company has also demonstrated its capabilities through third-party validations, achieving 36 percent efficiency on lab prototypes and 29 percent on pre-industrial modules. Insolight's business model focuses on developing intellectual property, controlling wholesale distribution, and outsourcing manufacturing. Additionally, the company is engaged in creating photovoltaic systems aimed at reducing solar electricity costs in the agricultural sector, employing integrated tracking methods to optimize energy production based on the sun's position.

Vestr is a technology company that specializes in providing a comprehensive software-as-a-service platform designed for the management of actively managed investment products. The company focuses on digitizing the entire value chain of active management, offering tools that facilitate portfolio management, order execution, and performance reporting. By streamlining these processes, Vestr enables issuers and portfolio managers to concentrate on their core competencies while efficiently managing their portfolios. The platform addresses the complexities of active management, allowing clients to make informed investment decisions and mitigate risk without issuing its own structured products.

Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

Metaco is a Swiss company that specializes in providing digital asset management solutions for financial institutions. It offers a comprehensive orchestration platform that allows institutions to issue, secure, manage, and trade a diverse range of digital assets, including cryptocurrencies, tokens, and smart contracts. The company’s platform supports the entire lifecycle of asset tokens with a robust smart contract framework, facilitating the management of various asset classes such as equities, bonds, and derivatives. Metaco's technology ensures a secure and agile digital asset vault for self-custody, while also providing connectivity to over 50 exchanges, brokers, and market makers, thus enabling seamless trading and efficient risk management for its clients.

Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Skribble is an electronic signature platform founded in 2018 and headquartered in Zurich, Switzerland. It provides a legally compliant solution for signing contracts electronically, ensuring that digital signatures carry the same legal weight as handwritten signatures under Swiss and EU law. The platform facilitates the signing process by allowing users to upload documents and manage signatures between parties, all with just a few clicks. Skribble aims to simplify the contract signing experience while maintaining the necessary legal integrity, making it a valuable tool for individuals and businesses seeking efficient document management.

PXL Vision AG, established in 2017 and headquartered in Zurich, Switzerland, specializes in designing and developing advanced identity verification software solutions. Its flagship product, Daego, is a cross-platform solution that creates trusted digital identities for customer onboarding through sophisticated document and identity verification using computer vision and machine learning technologies. PXL Vision operates research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, serving industries such as insurance, gambling, fintech, banking, and healthcare worldwide. The company aims to reduce customer onboarding costs, enhance conversion rates, and prevent fraud by providing unbiased, verifiable identities for secure digital interactions.

Livet designs and engineers medical devices. They include information on medical devices; a designed LED light source is built-in; and endoscopic examinations can be easily performed simply by connecting to a PC for monitoring.

Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

AVAtronics SA, established in 2016 and headquartered in Lausanne, Switzerland, specializes in the development of advanced noise cancelling technology for various electronic devices. The company's flagship product is an Active Noise Cancellation (ANC) solution designed to minimize power consumption while providing wide-band ANC. This technology selectively eliminates unwanted noises without degrading the quality of music or speech, making it suitable for applications such as headphones, earbuds, hearing aids, and speakerphones.

Annaida Technologies SA, founded in 2019 and based in Lausanne, Switzerland, specializes in the development of innovative healthcare devices. The company has created EmbryoSpin, a device that performs microscopic Nuclear Magnetic Resonance (µNMR) with a sensitivity that surpasses existing technologies by tenfold. This groundbreaking device is designed to operate at the scale of a single human embryo, providing a robust and user-friendly solution for researchers. EmbryoSpin facilitates non-invasive embryo viability screening for in-vitro fertilization and enhances biochemical research by allowing detailed chemical analysis of microscopic samples. Annaida Technologies' advancements aim to improve outcomes in reproductive health and deepen understanding in various areas of biochemical research.

Klepsydra Technologies GmbH is a software development company based in Zurich, Switzerland, founded in 2017. It specializes in providing a lightweight, platform-agnostic software engineering toolset designed for embedded systems. The company’s software facilitates the development of high-performance applications across various sectors, including aerospace, robotics, autonomous unmanned aerial vehicles, smart mobility, and Internet of Things (IoT) solutions. By offering a cloud computing tool, Klepsydra enables clients to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks such as sensor fusion and image processing. This positions Klepsydra as a versatile enabler of innovation, helping clients achieve ambitious goals through enhanced efficiency and effectiveness in their engineering processes.

Archilyse AG is a Zurich-based software company founded in 2017 that specializes in numeric architectural analysis. The firm offers a Software-as-a-Service solution that enables real estate professionals, including portfolio managers and developers, to analyze and optimize various processes throughout the real estate lifecycle. Archilyse's software converts 2D floor plans into 3D models and utilizes a range of simulations—such as view, geometrical, connectivity, and physical analysis—to derive valuable insights about architectural quality. The application allows users to visualize data through heatmaps and export key performance metrics for further analysis. By addressing the information imbalance in the real estate sector, Archilyse enhances the decision-making capabilities of its clients, promoting a more data-driven approach to property evaluation and portfolio management.

Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Apiax AG is a Swiss company founded in 2017, with offices in Zürich, Lisbon, and London, specializing in digital compliance solutions for the financial sector. It enables banks and FinTech companies to convert complex regulatory requirements into straightforward digital compliance rules. By leveraging machine learning and a high-performance architecture, Apiax provides an embedded compliance solution that allows financial institutions to integrate compliance seamlessly into their existing workflows and applications. This innovative approach helps organizations address regulatory challenges, capitalize on business opportunities, and reduce compliance costs, ultimately enhancing their operational efficiency and decision-making processes.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.